Figure 3From: Meta-analysis of trials comparing anastrozole and tamoxifen for adjuvant treatment of postmenopausal women with early breast cancer Forest plot of event free survival for anastrozole vs. tamoxifen in fixed-effect model in which ATAC trial was excluded. Test for heterogeneity (Q) = 0.490 (P = 0.783). HR: hazard rate, CI: confidence interval.Back to article page